Literature DB >> 30903920

Role of protein arginine methyltransferase 5 in human cancers.

Wendi Xiao1, Xiaoqing Chen2, Lisa Liu1, Yuansen Shu1, Min Zhang3, Yucheng Zhong4.   

Abstract

Protein arginine methyltransferases (PRMTs) play important roles in protein methylation. PRMT5 is the major type II arginine methyltransferase that catalyzes the transfer of two methyl groups symmetrically to the arginine residues of either histone or non-histone proteins. In recent years, increasing evidence has shown that PRMT5, as an oncogene, plays an indispensable regulatory role in the pathological progression of several human cancers by promoting the proliferation, invasion, and migration of cancer cells. PRMT5 is overexpressed in many malignant tumors and plays an important role in the occurrence and development of cancer, which suggests that PRMT5 may become a potential biomarker or therapeutic target of cancer. This article reviews the biological function, mechanism, and clinical significance of PRMT5 in tumorigenesis.
Copyright © 2019. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Biomarker; Cancer; Oncogene; PRMT5

Mesh:

Substances:

Year:  2019        PMID: 30903920     DOI: 10.1016/j.biopha.2019.108790

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  24 in total

1.  Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5-MEP50 Complex.

Authors:  Adrian Krzyzanowski; Raphael Gasper; Hélène Adihou; Peter 't Hart; Herbert Waldmann
Journal:  Chembiochem       Date:  2021-03-31       Impact factor: 3.164

Review 2.  Small molecule targeting of chromatin writers in cancer.

Authors:  Andrew R Conery; Jennifer L Rocnik; Patrick Trojer
Journal:  Nat Chem Biol       Date:  2021-12-24       Impact factor: 15.040

3.  UBX Domain Protein 6 Positively Regulates JAK-STAT1/2 Signaling.

Authors:  Harshada Ketkar; Andrew G Harrison; Vincent R Graziano; Tingting Geng; Long Yang; Anthony T Vella; Penghua Wang
Journal:  J Immunol       Date:  2021-05-21       Impact factor: 5.426

4.  PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2V617F-Mutant MPN.

Authors:  Friederike Pastore; Neha Bhagwat; Alessandro Pastore; Aliaksandra Radzisheuskaya; Abdul Karzai; Aishwarya Krishnan; Bing Li; Robert L Bowman; Wenbin Xiao; Aaron D Viny; Anouar Zouak; Young C Park; Keith B Cordner; Stephanie Braunstein; Jesper L Maag; Alexander Grego; Jaanvi Mehta; Min Wang; Hong Lin; Benjamin H Durham; Richard P Koche; Raajit K Rampal; Kristian Helin; Peggy Scherle; Kris Vaddi; Ross L Levine
Journal:  Cancer Discov       Date:  2020-07-15       Impact factor: 38.272

5.  PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach.

Authors:  Marcella Barbarino; Daniele Cesari; Maria Bottaro; Luca Luzzi; Asadoor Namagerdi; Franca Maria Bertolino; Cristiana Bellan; Fabrizio Proietti; Pasquale Somma; Mariacarolina Micheli; Maria Margherita de Santi; Raffaella Guazzo; Luciano Mutti; Luigi Pirtoli; Piero Paladini; Paola Indovina; Antonio Giordano
Journal:  J Cell Mol Med       Date:  2020-04-17       Impact factor: 5.310

6.  Discovery of a First-in-Class Inhibitor of the PRMT5-Substrate Adaptor Interaction.

Authors:  David C McKinney; Brian J McMillan; Matthew J Ranaghan; Jamie A Moroco; Merissa Brousseau; Zachary Mullin-Bernstein; Meghan O'Keefe; Patrick McCarren; Michael F Mesleh; Kathleen M Mulvaney; Foxy Robinson; Ritu Singh; Besnik Bajrami; Florence F Wagner; Robert Hilgraf; Martin J Drysdale; Arthur J Campbell; Adam Skepner; David E Timm; Dale Porter; Virendar K Kaushik; William R Sellers; Alessandra Ianari
Journal:  J Med Chem       Date:  2021-08-03       Impact factor: 8.039

7.  PRMT5 Promotes Human Lung Cancer Cell Apoptosis via Akt/Gsk3β Signaling Induced by Resveratrol.

Authors:  Yong Li; Yanxia Yang; Xiaoping Liu; Yiwen Long; Yonghua Zheng
Journal:  Cell Transplant       Date:  2019-10-30       Impact factor: 4.064

8.  PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.

Authors:  Antja-Voy Hartley; Benlian Wang; Rasika Mundade; Guanglong Jiang; Mengyao Sun; Han Wei; Steven Sun; Yunlong Liu; Tao Lu
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

Review 9.  Histone methyltransferase and drug resistance in cancers.

Authors:  Cheng Yang; Jiayu Zhang; Yukui Ma; Chunfu Wu; Wei Cui; Lihui Wang
Journal:  J Exp Clin Cancer Res       Date:  2020-08-28

10.  Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway.

Authors:  Iwona Bednarz-Misa; Paulina Fortuna; Mariusz G Fleszar; Łukasz Lewandowski; Dorota Diakowska; Joanna Rosińczuk; Małgorzata Krzystek-Korpacka
Journal:  Int J Mol Sci       Date:  2020-08-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.